Eswatini is the first African nation to receive lenacapavir, a groundbreaking HIV prevention injection administered twice yearly. Global health officials have hailed this medication, developed by ...

But the rollout is now being wielded as a political tool. What that “America First” slogan actually means for global health ...

Health experts are alarmed as Republicans degrade the country’s pivotal HIV programs — and break promises made during Trump’s ...

Opportunistic infections target people with weakened immune systems, including those with HIV. These conditions can lead to ...

Lenacapavir is a twice-yearly injectable drug produced by Gilead Sciences that is aimed at preventing HIV infection. In 2024, ...

Medicaid expansion under the Affordable Care Act (ACA) significantly increased the number of people at risk of HIV diagnosis ...

Rutgers Health researchers found that prescription rates for preexposure prophylaxis rose overall, but racial disparities ...